InvestorsHub Logo
Followers 73
Posts 6214
Boards Moderated 0
Alias Born 05/01/2011

Re: HinduKush post# 269873

Tuesday, 04/28/2020 4:08:15 PM

Tuesday, April 28, 2020 4:08:15 PM

Post# of 426264
Generics can’t market the CV label.

It’s like having a Ferrari dealership that’s only allowed to sell tires.

Generic Vascepa with no marketing beyond hypertrigs is a kissing-your-sister proposition.

Amarin still has considerable leverage. This is the unintended consequence of the skinny label rules. They weren’t designed with this unique development pattern in mind.

“The trick is in what one emphasizes. We either make ourselves miserable, or we make ourselves happy. The amount of work is the same.” Carlos Castaneda

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News